Safety and Efficacy of Periprocedural Anticoagulation With Enoxaparin in Patients Undergoing Peripheral Endovascular Revascularization

Conclusion: We conclude that low-molecular-weight heparin either in a low-dose or high-dose regime during a peripheral EVR is safe concerning bleeding complications and acute reobstructions. The long-term follow-up showed no significant difference between our high- and low-risk groups concerning reobstruction. The periprocedural anticoagulation seems to have no influence on the long-term patency rate after peripheral EVR.

http://cat.sagepub.com/cgi/content/abstract/20/5/530?rss=1

Source: Clinical and Applied Thrombosis/Hemostasis - May 26, 2014 Category: Hematology Authors: Brodmann, M., Dorr, A., Hafner, F., Gary, T., Froehlich, H., Kvas, E., Deutschmann, H., Pilger, E. Tags: Original Articles Source Type: research